Karen Madsen

Potentiating the benefit of vascular-supplied glutamine during small bowel storage: importance of buffering agent.

MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism.

Peroxynitrite enhances the ability of Salmonella dublin to invade T84 monolayers.

Defining the role of a tailored luminal solution for small bowel preservation.

Antisense oligonucleotides to poly(ADP-ribose) polymerase-2 ameliorate colitis in interleukin-10-deficient mice.

Normal Breast Milk Limits the Development of Colitis in IL-10-Deficient Mice.

Combining T cells and IL-10: a new therapy for Crohn's disease?

Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.

Intestinal decontamination using povidone-iodine compromises small bowel storage quality.

Activation of AMP-activated protein kinase reduces cAMP-mediated epithelial chloride secretion.

Human small bowel storage: the role for luminal preservation solutions.

Alleviating ischemia-reperfusion injury in small bowel.

DNA from probiotic bacteria modulates murine and human epithelial and immune function.

Probiotics and the management of inflammatory bowel disease.

Ameliorating small bowel injury using a cavitary two-layer preservation method with perfluorocarbon and a nutrient-rich solution.

5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK.

Probiotics and prebiotics in gastrointestinal disorders.

Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells.

VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.

Postoperative Crohn's disease.

The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.

Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases.

Adenosine is a negative regulator of NF-kappaB and MAPK signaling in human intestinal epithelial cells.

AMP-activated protein kinase is a positive regulator of poly(ADP-ribose) polymerase.

Control of oxidative stress in small bowel: relevance to organ preservation.

Probiotics and the immune response.

Recommendations for probiotic use.

Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice.

Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map).

The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients.

The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.

Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.

Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial.

Relationship between energetic stress and pro-apoptotic/cytoprotective kinase mechanisms in intestinal preservation.

Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis.

VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation.

Alleviating intestinal ischemia-reperfusion injury in an in vivo large animal model: developing an organ-specific preservation solution.

Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function.

Probiotics in critically ill patients.

Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study.

Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.

Grading of inflammatory disease activity in the sacroiliac joints with magnetic resonance imaging: comparison between short-tau inversion recovery and gadolinium contrast-enhanced sequences.

Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint.

Prognostic significance of magnetic resonance imaging changes of the sacroiliac joints in spondyloarthritis--a followup study.

MD-2: another important piece of the puzzle?

Mind the gaps: confocal endomicroscopy showed increased density of small bowel epithelial gaps in inflammatory bowel disease.

cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation.

Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings.

Estrogen receptor-β signaling modulates epithelial barrier function.

Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress.

Using metabolomics to decipher probiotic effects in patients with irritable bowel syndrome.

Human gut microbiota and its relationship to health and disease.

Glutamine supplementation improves intestinal barrier function in a weaned piglet model of Escherichia coli infection.

The International Scientific Conference on Probiotics and Prebiotics.

Interactions between microbes and the gut epithelium.

Recommendations for probiotic use-2011 update.

Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice.

Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNA.

Fat and carbohydrate metabolism during exercise in late-onset Pompe disease.

Non-specific abdominal pain and air pollution: a novel association.

Epithelial gaps in a rodent model of inflammatory bowel disease: a quantitative validation study.

Exercise intolerance in Glycogen Storage Disease Type III: weakness or energy deficiency?

Epithelial cell extrusion leads to breaches in the intestinal epithelium.

Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy.

Environment and the inflammatory bowel diseases.

Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome.

Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome.

Ambient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study.

VSL#3(®) probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis.

Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies.

Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.

Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease.

Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile.

Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review.

Exposure to ingested airborne pollutant particulate matter increases mucosal exposure to bacteria and induces early onset of inflammation in neonatal IL-10-deficient mice.

Perturbation of the human microbiome as a contributor to inflammatory bowel disease.

The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.

Increasing small intestinal permeability worsens colitis in the IL-10-/- mouse and prevents the induction of oral tolerance to ovalbumin.

Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.

Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.

Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.

Fecal Microbial Transplant After Ileocolic Resection Reduces Ileitis but Restores Colitis in IL-10-/- Mice.

Western diet-induced anxiolytic effects in mice are associated with alterations in tryptophan metabolism.

Soluble Dextrin Fibers Alter the Intestinal Microbiota and Reduce Proinflammatory Cytokine Secretion in Male IL-10-Deficient Mice.

Intravenous immunoglobulin skews macrophages to an anti-inflammatory, IL-10-producing activation state.

Fecal microbiota transplantation in the management of hepatic encephalopathy.

Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.

Upper gastrointestinal bleeding due to peptic ulcer disease is not associated with air pollution: a case-crossover study.

Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.

Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.

Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics.

Reply to Jouhten et al.

Improved Glucose Homeostasis in Obese Mice Treated With Resveratrol Is Associated With Alterations in the Gut Microbiome.

Fecal microbial transplantation as a therapeutic option in patients colonized with antibiotic resistant organisms.

Dietary and metabolomic determinants of relapse in ulcerative colitis patients: A pilot prospective cohort study.

Metabolomic profiling to characterize acute intestinal ischemia/reperfusion injury.

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: A randomized controlled trial.

Fecal microbiota transplantation for hepatic encephalopathy: Ready for prime time?

Fecal Microbiota Transplantation: Beyond Clostridium difficile.

Ileocolic resection is associated with increased susceptibility to injury in a murine model of colitis.

Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Prebiotic Supplementation Following Ileocecal Resection in a Murine Model is Associated With a Loss of Microbial Diversity and Increased Inflammation.

A BACH2 Gene Variant Is Associated with Postoperative Recurrence of Crohn's Disease.

A Distinctive Urinary Metabolomic Fingerprint Is Linked With Endoscopic Postoperative Disease Recurrence in Crohn's Disease Patients.

Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice.

Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn's disease.

Creatine-loading preserves intestinal barrier function during organ preservation.

Lower Abundance and Impaired Function of CD71+ Erythroid Cells in Inflammatory Bowel Disease Patients During Pregnancy.

The Profile of Human Milk Metabolome, Cytokines, and Antibodies in Inflammatory Bowel Diseases Versus Healthy Mothers, and Potential Impact on the Newborn.

Impact of dietary fiber supplementation on modulating microbiota-host-metabolic axes in obesity.

Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases.

Ongoing Inconsistencies in Weight Loss Reporting Following Bariatric Surgery: a Systematic Review.

Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers.

Clostridium difficile and Laparoscopic Bariatric Surgery: an Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database.

The success of fecal microbial transplantation in infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study.

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.

Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial.

Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production.

Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations.

Predicting surgical site infections following laparoscopic bariatric surgery: development of the BariWound tool using the MBSAQIP database.

Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.

Diet in the Pathogenesis and Management of Ulcerative Colitis; A Review of Randomized Controlled Dietary Interventions.

A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice.

Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome-A Systematic Review.

Sex and Race Predict Adverse Outcomes Following Bariatric Surgery: an MBSAQIP Analysis.

Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats.

Response to Mocanu et al. Ongoing Inconsistencies in Weight Loss Reporting Following Bariatric Surgery: a Systematic Review. Obesity Surgery https://doi.org/10.1007/s11695-018-03702-6Mocanu.

Effect of chicory inulin-type fructan-containing snack bars on the human gut microbiota in low dietary fiber consumers in a randomized crossover trial.

A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.

Application of metabolomics to the study of irritable bowel syndrome.

Sex-Specific Differences in the Gut Microbiome in Response to Dietary Fiber Supplementation in IL-10-Deficient Mice.

The Gut Microbiota Profile in Children with Prader-Willi Syndrome.

Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.

Adipose Tissue Development and Expansion from the Womb to Adolescence: An Overview.

IMAGINE Network's ind nd ut nteractions ohort (MAGIC) Study: a protocol for a prospective observational multicentre cohort study in inflammatory bowel disease and irritable bowel syndrome.

The Promise of Maintaining Diet-Induced Weight Loss by Swallowing One's Own Feces: Time to Provide a Do-It-Yourself Manual?

Erratum to: A Diversified Dietary Pattern Is Associated With a Balanced Gut Microbial Composition of Faecalibacterium and Escherichia/Shigella in Patients With Crohn's Disease in Remission.

The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.

Dietary patterns, food groups and nutrients in Crohn's disease: associations with gut and systemic inflammation.

Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.

Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis.

What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis.

Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review.

Timing of Tributyrin Supplementation Differentially Modulates Gastrointestinal Inflammation and Gut Microbial Recolonization Following Murine Ileocecal Resection.

Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.

Composition and Functions of the Gut Microbiome in Pediatric Obesity: Relationships with Markers of Insulin Resistance.